Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI

This study is ongoing, but not recruiting participants.
Information provided by Universitaria di Ferrara

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Myocardial Infarction
2		Additional conditions recognized in this trial
			Infarction
3		More general conditions related to this trial
			Cardiovascular Diseases
			Heart Diseases
			Ischemia
			Myocardial Ischemia
			Necrosis
			Pathologic Processes
			Vascular Diseases
4		Interventions listed in this trial
			tirofiban and bare metal stent
5		Additional drug interventions recognized in this trial
			Abciximab
			PS-K
			Sirolimus
			Tirofiban
6		More general drug interventions related to this trial
			Adjuvants, Immunologic
			Anti-Bacterial Agents
			Anti-Infective Agents
			Antibiotics, Antineoplastic
			Anticoagulants
			Antifungal Agents
			Antineoplastic Agents
			Antiviral Agents
			Cardiovascular Agents
			Fibrin Modulating Agents
			Fibrinolytic Agents
			Hematologic Agents
			Immunologic Factors
			Immunosuppressive Agents
			Interferon Inducers
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Physiological Effects of Drugs
			Platelet Aggregation Inhibitors
			Protective Agents
			Radiation-Protective Agents
			Therapeutic Uses
7		Sponsors listed in this trial
			Universitaria di Ferrara